Send us a link
Limited initial supply of SARS-CoV-2 vaccine raises the question of how to prioritize available doses. The authors used a mathematical model to compare five age-stratified prioritization strategies.
In the age of the internet, there's no such thing as a private debate. But is that bad for science?
Herd immunity is expected to arise when a virus cannot spread readily. However, Manaus provides a cautionary example that herd immunity is likely not achieved even at high levels of infection and that it comes with unacceptably high costs.
Over the past few weeks, prominent scientific publications have condemned President Donald Trump's record on science. This is unprecedented.
In another candid interview, the NIAID director explains how he tries to counters White House optimism with "reality".
New data quantify lost work hours and productivity, but the way forward remains uncertain.
Science journals will have to disclose the costs of publishing articles by July 2022 in order for them to be paid for by a coalition of research funders pushing for open access.
Virologist Peter Piot, director of the London School of Hygiene & Tropical Medicine, fell ill with COVID-19 in mid-March.
A public-private partnership and platform for harmonized clinical trials aims to accelerate licensure and distribution.
In the video Plandemic, the former chronic fatigue syndrome researcher makes countless unsubstantiated claims and accusations.
After decades of debate on the feasibility of open access (OA) to scientific publications, we may be nearing a tipping point. A number of recent developments, such as Plan S, suggest that OA upon publication could become the default in the sciences within the next several years. However, there remains a need for practical, sustainable models, for careful analysis of the consequences of business model choices, and for caution in responding to passionate calls for a 'default to open'.
The U.S. National Institutes of Health (NIH) is in the midst of digesting public comments toward finalizing a data sharing policy. Although the draft policy is generally supportive of data sharing, it needs strengthening if we are to collectively achieve a long-standing vision of open science built on the FAIR principles.
A report from joint WHO-China mission takes a detailed look at the results of response in the country hit hardest.
Chinese researchers say a novel coronavirus likely sickened 59 people in Wuhan.
Florida lawmakers have begun an investigation into the foreign ties of researchers at the state’s universities and research institutions. The inquiry dovetails with an ongoing federal probe into whether such affiliations, notably with Chinese entities, pose a risk to the U.S. research enterprise.
NIH gets 7%, NSF only 2.5%, as Congress ignores Trump's proposed cuts.
Sudip Parikh will become the new CEO of AAAS (which publishes Science) as the 171-year-old association pursues its mission to advance science and serve society.
Court prevents publicity for investigations into Heidelberg University Hospital cancer test scandal
The U.S. health care system uses commercial algorithms to guide health decisions. Obermeyer et al. find evidence of racial bias in one widely used algorithm, such that Black patients assigned the same level of risk by the algorithm are sicker than White patients (see the Perspective by Benjamin). The authors estimated that this racial bias reduces the number of Black patients identified for extra care by more than half.
The rule, if implemented, would hinder grad student unionization efforts at private U.S. universities.
Concerns include declining volume, slower publication, and softening citation measures.
The financial strain of having a baby during her Ph.D. put this researcher's career in jeopardy.
The Native Hawaiian protesters blocking the construction of the Thirty Meter Telescope on the summit of Mauna Kea appear to have settled in for the long haul.
The long-standing debate over open access to research results has been marked by a geographic divide - but the divide is starting to blur.
Experimental Ebola treatments carried out in the Democratic Republic of the Congo (DRC) have shown strong signs of being able to save patients’ lives.
Legislators weigh steps to thwart foreign attacks on academic research.
